As of 2026-10-03, the Relative Valuation of Infinity Pharmaceuticals Inc (INFI) is (31.45) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.04 USD, the upside of Infinity Pharmaceuticals Inc based on Relative Valuation is -70453.1%.
The range of the Relative Valuation is (26.02) - (34.56) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.6x - 27.4x | 24.9x |
| Forward P/E multiples | 19.5x - 27.9x | 25.0x |
| Fair Price | (26.02) - (34.56) | (31.45) |
| Upside | -58299.9% - -77418.0% | -70453.1% |
| Date | P/E |